Filings signal: Despite Covid losses, pharma earnings are promising
Despite losing out on Covid sales as government funding drops off, pharma earnings look promising in the second half of 2023.
Despite losing out on Covid sales as government funding drops off, pharma earnings look promising in the second half of 2023.
What's Your Reaction?
